| Common Name | MEDI4736 |
|---|---|
| Synonyms | PD-L1;CD274;B7-H1;PDCD1L1;PDCD1LG1 |
| Applications | Flow Cyt |
| Recommended Dilutions | Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Host Species | Humanized |
| IgG type | IgG1(K97R, L117F, L118E, P214S) |
| Reactivity | Human |
| Target | |
| Uniprot ID | Q9NZQ7 |
| Description | Anti-PDL1 (durvalumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
Anti-PDL1 (durvalumab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. Flow cytometry analysis with 1 μg/mL Anti-PDL1(durvalumab biosimilar) mAb (BME100153) on Expi293 cells transfected with Human PDL1 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
Figure 2. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human PDL1, mFc-His tagged protein (PME100023) can bind Anti-PDL1 (durvalumab biosimilar) Neutralizing antibody (BME100153) in a linear range of 0.61-9.77 ng/ml.